Tilli MT - Search Results

1

Introduction of estrogen receptor-alpha into the tTA/TAg conditional mouse model precipitates the development of estrogen-responsive mammary adenocarcinoma.

Tilli MT, Frech MS, Steed ME, Hruska KS, Johnson MD, Flaws JA, Furth PA. Tilli MT, et al. Am J Pathol. 2003 Nov;163(5):1713-9. doi: 10.1016/s0002-9440(10)63529-8. Am J Pathol. 2003. PMID: 14578170 Free PMC article.

2

Conditional over-expression of estrogen receptor alpha in a transgenic mouse model.

Hruska KS, Tilli MT, Ren S, Cotarla I, Kwong T, Li M, Fondell JD, Hewitt JA, Koos RD, Furth PA, Flaws JA. Hruska KS, et al. Among authors: tilli mt. Transgenic Res. 2002 Aug;11(4):361-72. doi: 10.1023/a:1016376100186. Transgenic Res. 2002. PMID: 12212839

3

Conditional mouse models demonstrate oncogene-dependent differences in tumor maintenance and recurrence.

Tilli MT, Furth PA. Tilli MT, et al. Breast Cancer Res. 2003;5(4):202-5. doi: 10.1186/bcr614. Epub 2003 May 30. Breast Cancer Res. 2003. PMID: 12817992 Free PMC article.

4

Loss of protein phosphatase 2A expression correlates with phosphorylation of DP-1 and reversal of dysplasia through differentiation in a conditional mouse model of cancer progression.

Tilli MT, Hudgins SL, Frech MS, Halama ED, Renou JP, Furth PA. Tilli MT, et al. Cancer Res. 2003 Nov 15;63(22):7668-73. Cancer Res. 2003. PMID: 14633688

5

Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ.

Frech MS, Halama ED, Tilli MT, Singh B, Gunther EJ, Chodosh LA, Flaws JA, Furth PA. Frech MS, et al. Among authors: tilli mt. Cancer Res. 2005 Feb 1;65(3):681-5. Cancer Res. 2005. PMID: 15705859 Free PMC article.

6

Chemoprevention of mammary carcinogenesis in a transgenic mouse model by alpha-difluoromethylornithine (DFMO) in the diet is associated with decreased cyclin D1 activity.

Li M, Ren S, Tilli MT, Flaws JA, Lubet R, Grubbs CJ, Furth PA. Li M, et al. Among authors: tilli mt. Oncogene. 2003 May 1;22(17):2568-72. doi: 10.1038/sj.onc.1206314. Oncogene. 2003. PMID: 12730671

7

Explant-cell culture of primary mammary tumors from MMTV-c-Myc transgenic mice.

Pei XF, Noble MS, Davoli MA, Rosfjord E, Tilli MT, Furth PA, Russell R, Johnson MD, Dickson RB. Pei XF, et al. Among authors: tilli mt. In Vitro Cell Dev Biol Anim. 2004 Jan-Feb;40(1-2):14-21. doi: 10.1290/1543-706X(2004)40<14:ECOPMT>2.0.CO;2. In Vitro Cell Dev Biol Anim. 2004. PMID: 15180438

8

Reflectance confocal microscopy for characterization of mammary ductal structures and development of neoplasia in genetically engineered mouse models of breast cancer.

Parrish A, Halama E, Tilli MT, Freedman M, Furth PA. Parrish A, et al. Among authors: tilli mt. J Biomed Opt. 2005 Sep-Oct;10(5):051602. doi: 10.1117/1.2065827. J Biomed Opt. 2005. PMID: 16292950 Free article.

9

Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer.

Jones LP, Tilli MT, Assefnia S, Torre K, Halama ED, Parrish A, Rosen EM, Furth PA. Jones LP, et al. Among authors: tilli mt. Oncogene. 2008 Jan 31;27(6):794-802. doi: 10.1038/sj.onc.1210674. Epub 2007 Jul 23. Oncogene. 2008. PMID: 17653086 Free PMC article.

10

Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.

Tilli MT, Reiter R, Oh AS, Henke RT, McDonnell K, Gallicano GI, Furth PA, Riegel AT. Tilli MT, et al. Mol Endocrinol. 2005 Mar;19(3):644-56. doi: 10.1210/me.2004-0106. Epub 2004 Nov 18. Mol Endocrinol. 2005. PMID: 15550471

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page